» Articles » PMID: 22851704

Chitin Elicits CCL2 from Airway Epithelial Cells and Induces CCR2-dependent Innate Allergic Inflammation in the Lung

Overview
Journal J Immunol
Date 2012 Aug 2
PMID 22851704
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Chitin exposure in the lung induces eosinophilia and alternative activation of macrophages and is correlated with allergic airway disease. However, the mechanism underlying chitin-induced polarization of macrophages is poorly understood. In this paper, we show that chitin induces alternative activation of macrophages in vivo but does not do so directly in vitro. We further show that airway epithelial cells bind chitin in vitro and produce CCL2 in response to chitin both in vitro and in vivo. Supernatants of chitin-exposed epithelial cells promoted alternative activation of macrophages in vitro, whereas Ab neutralization of CCL2 in the supernate abolished the alternative activation of macrophages. CCL2 acted redundantly in vivo, but mice lacking the CCL2 receptor, CCR2, showed impaired alternative activation of macrophages in response to chitin, as measured by arginase I, CCL17, and CCL22 expression. Furthermore, CCR2 knockout mice exposed to chitin had diminished reactive oxygen species products in the lung, blunted eosinophil and monocyte recruitment, and impaired eosinophil functions as measured by expression of CCL5, IL-13, and CCL11. Thus, airway epithelial cells secrete CCL2 in response to chitin and CCR2 signaling mediates chitin-induced alternative activation of macrophages and allergic inflammation in vivo.

Citing Articles

An ILC2-chitinase circuit restores lung homeostasis after epithelial injury.

Jung H, Kim D, Diaz R, White J, Rucknagel S, Mosby L Sci Immunol. 2024; 9(100):eadl2986.

PMID: 39423283 PMC: 11854321. DOI: 10.1126/sciimmunol.adl2986.


Fungal chitin-binding glycoprotein induces Dectin-2-mediated allergic airway inflammation synergistically with chitin.

Muraosa Y, Hino Y, Takatsuka S, Watanabe A, Sakaida E, Saijo S PLoS Pathog. 2024; 20(1):e1011878.

PMID: 38170734 PMC: 10763971. DOI: 10.1371/journal.ppat.1011878.


Tumor-associated macrophages: Prognostic and therapeutic targets for cancer in humans and dogs.

Brady R, Thamm D Front Immunol. 2023; 14:1176807.

PMID: 37090720 PMC: 10113558. DOI: 10.3389/fimmu.2023.1176807.


They shall not grow mold: Soldiers of innate and adaptive immunity to fungi.

Woodring T, Deepe G, Levitz S, Wuethrich M, Klein B Semin Immunol. 2022; 65:101673.

PMID: 36459927 PMC: 10311222. DOI: 10.1016/j.smim.2022.101673.


MCP-1 targeting: Shutting off an engine for tumor development.

Wang L, Lan J, Tang J, Luo N Oncol Lett. 2021; 23(1):26.

PMID: 34868363 PMC: 8630816. DOI: 10.3892/ol.2021.13144.


References
1.
Nishiyama A, Shinohara T, Pantuso T, Tsuji S, Yamashita M, Shinohara S . Depletion of cellular cholesterol enhances macrophage MAPK activation by chitin microparticles but not by heat-killed Mycobacterium bovis BCG. Am J Physiol Cell Physiol. 2008; 295(2):C341-9. PMC: 2518411. DOI: 10.1152/ajpcell.00446.2007. View

2.
Casola A, Saito T, Alam R, Crowe S, Mei F, Ogra P . Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol. 1998; 72(6):4756-64. PMC: 110009. DOI: 10.1128/JVI.72.6.4756-4764.1998. View

3.
Rozen S, Skaletsky H . Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 1999; 132:365-86. DOI: 10.1385/1-59259-192-2:365. View

4.
Holgate S, Bodey K, JANEZIC A, Frew A, Kaplan A, Teran L . Release of RANTES, MIP-1 alpha, and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med. 1997; 156(5):1377-83. DOI: 10.1164/ajrccm.156.5.9610064. View

5.
Rothenberg M, Hogan S . The eosinophil. Annu Rev Immunol. 2006; 24:147-74. DOI: 10.1146/annurev.immunol.24.021605.090720. View